Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Victoza vs Metformin on Vascular Function in T2DM and CAD
NCT03010683Completed
- Sponsor
- National and Kapodistrian University of Athens
- Start
- Nov 2015
- Primary completion
- Jun 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, open-label trial of liraglutide in type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD), sponsored by National and Kapodistrian University of Athens. Primary endpoint: Pulse Wave Velocity at 12 months. Started Nov 2015; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT03010683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03010683.